12/19
05:58 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
12/18
07:17 am
fhtx
Rating for FHTX
High
Report
Rating for FHTX
12/18
07:11 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
High
Report
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
12/18
06:53 am
fhtx
Foghorn Therapeutics initiated with a Buy at BTIG
High
Report
Foghorn Therapeutics initiated with a Buy at BTIG
12/4
11:55 am
fhtx
Rating for FHTX
Low
Report
Rating for FHTX
12/3
04:18 pm
fhtx
Foghorn Therapeutics initiated with a Buy at Stifel
Medium
Report
Foghorn Therapeutics initiated with a Buy at Stifel
11/7
11:27 am
fhtx
Rating for FHTX
Medium
Report
Rating for FHTX
11/7
11:27 am
fhtx
Rating for FHTX
Medium
Report
Rating for FHTX
11/7
08:45 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
Medium
Report
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
11/7
08:45 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
Medium
Report
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
11/7
06:27 am
fhtx
Foghorn Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Foghorn Therapeutics initiated with a Buy at Guggenheim
11/7
06:27 am
fhtx
Foghorn Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Foghorn Therapeutics initiated with a Buy at Guggenheim
11/6
01:21 pm
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
11/6
01:21 pm
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.